Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
15%
Ph phase_2
2
15%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(9)
Other(4)

Detailed Status

Completed9
unknown4

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (50.0%)
N/A2 (50.0%)

Trials by Status

unknown431%
completed969%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials
NCT00898495

Genes in Predicting Outcome in Patients With Esophageal Cancer Treated With Cisplatin, Radiation Therapy, and Surgery

Completed
NCT00095589

Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer

Completed
NCT00897819

Studying DNA and Outcome in Patients With Advanced Colorectal Cancer Treated With Fluorouracil and Oxaliplatin With or Without Bevacizumab on Clinial Trial E-3200

Completed
NCT01004523

Study of Tissue and Blood Samples From Patients With Low-Grade Glioma

Completed
NCT00014079

Genetic Markers in Patients With Colorectal Cancer

Completed
NCT00896766

Laboratory Study of Lymphoblasts in Young Patients With High-Risk Acute Lymphoblastic Leukemia

Completed
NCT01004783

Biomarkers in Tumor Tissue Samples From Young Patients With Very Low Risk Wilms Tumors

Completed
NCT00004210Not Applicable

Study of the Results of Education and Counseling for Persons Undergoing Genetic Testing for Hereditary Nonpolyposis Colon Cancer

Completed
NCT00671476Not Applicable

Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery

Unknown
NCT00360945Phase 2

Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma

Unknown
NCT00896818

Genes and Other Risk Factors for Second Primary Breast Cancer in Women With Breast Cancer and Their Female Family Members and Friends

Unknown
NCT00693836

Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region

Unknown
NCT00057798Phase 2

Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery

Completed

All 13 trials loaded

Drug Details

Intervention Type
GENETIC
Total Trials
13